Press Release

Daiichi Sankyo Announces Appointment of CxOs

Tokyo, Japan - (March 31, 2023) - Daiichi Sankyo Company, Limited today announced the appointment of CxOs under the Global Management Structure effective from April 1, 2023.

1. CEO, COO

CxO

Name

Chief Executive Officer*

Sunao Manabe

(CEO)

Chief Operating Officer*

Hiroyuki Okuzawa

(COO)

2. CxO

As the heads of specific functions, CxOs will oversee the activities of our entire group from a management perspective, possess advanced and comprehensive expertise to their respective functional areas, and work to improve corporate value and address management issues.

CxO

Name

Head of Global Function

Chief Strategy Officer

Takashi Fukuoka

Head of Global Corporate Strategy*

(CStO)

Chief Financial Officer*

Koji Ogawa

Head of Global Corporate Planning &

(CFO)

Management*

Chief Digital Transformation Officer

Masahiko Ohtsuki

Head of Global DX*

(CDXO)

Chief Human Resources Officer

Takashi Matsumoto

Head of Global HR*

(CHRO)

General Counsel

Naoto Tsukaguchi

Head of Global Legal & IP*

(GC)

  • The appointment of these positions was announced in the press release "Daiichi Sankyo Announces Global Management Structure and Corporate Officers" on February 21, 2023

About Daiichi Sankyo

Daiichi Sankyo is dedicated to creating new modalities and innovative medicines by leveraging our world- class science and technology for our purpose "to contribute to the enrichment of quality of life around the world." In addition to our current portfolio of medicines for cancer and cardiovascular disease, Daiichi

1

Sankyo is primarily focused on developing novel therapies for people with cancer as well as other diseases with high unmet medical need. With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 16,000 employees around the world draw upon a rich legacy of innovation to realize our 2030 Vision to become an "Innovative Global Healthcare Company Contributing to the Sustainable Development of Society." For more information, please visit www.daiichisankyo.com.

Media Contacts:

Japan:

Investor Relations Contact:

Koji Ogiwara

DaiichiSankyoIR@daiichisankyo.co.jp

Daiichi Sankyo Co., Ltd.

ogiwara.koji.ay@daiichisankyo.co.jp

+81 3 6225 1126 (office)

2

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Daiichi Sankyo Co. Ltd. published this content on 31 March 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 April 2023 12:59:10 UTC.